
ALAB Valuation
Astera Labs Inc
- Overview
- Forecast
- Valuation
- Earnings
ALAB Relative Valuation
ALAB's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ALAB is overvalued; if below, it's undervalued.
Historical Valuation
Astera Labs Inc (ALAB) is now in the Overvalued zone, suggesting that its current forward PE ratio of 139.22 is considered Overvalued compared with the five-year average of 91.09. The fair price of Astera Labs Inc (ALAB) is between 89.46 to 181.24 according to relative valuation methord. Compared to the current price of 228.00 USD , Astera Labs Inc is Overvalued By 25.8%.
Relative Value
Fair Zone
89.46-181.24
Current Price:228.00
25.8%
Overvalued
139.22
PE
1Y
3Y
5Y
Trailing
Forward
119.20
EV/EBITDA
Astera Labs Inc. (ALAB) has a current EV/EBITDA of 119.20. The 5-year average EV/EBITDA is 65.90. The thresholds are as follows: Strongly Undervalued below -121.72, Undervalued between -121.72 and -27.91, Fairly Valued between 159.71 and -27.91, Overvalued between 159.71 and 253.52, and Strongly Overvalued above 253.52. The current Forward EV/EBITDA of 119.20 falls within the Historic Trend Line -Fairly Valued range.
123.72
EV/EBIT
Astera Labs Inc. (ALAB) has a current EV/EBIT of 123.72. The 5-year average EV/EBIT is 80.08. The thresholds are as follows: Strongly Undervalued below 13.27, Undervalued between 13.27 and 46.67, Fairly Valued between 113.49 and 46.67, Overvalued between 113.49 and 146.89, and Strongly Overvalued above 146.89. The current Forward EV/EBIT of 123.72 falls within the Overvalued range.
46.12
PS
Astera Labs Inc. (ALAB) has a current PS of 46.12. The 5-year average PS is 24.96. The thresholds are as follows: Strongly Undervalued below 8.16, Undervalued between 8.16 and 16.56, Fairly Valued between 33.37 and 16.56, Overvalued between 33.37 and 41.77, and Strongly Overvalued above 41.77. The current Forward PS of 46.12 falls within the Strongly Overvalued range.
141.67
P/OCF
Astera Labs Inc. (ALAB) has a current P/OCF of 141.67. The 5-year average P/OCF is 92.58. The thresholds are as follows: Strongly Undervalued below -10.16, Undervalued between -10.16 and 41.21, Fairly Valued between 143.95 and 41.21, Overvalued between 143.95 and 195.32, and Strongly Overvalued above 195.32. The current Forward P/OCF of 141.67 falls within the Historic Trend Line -Fairly Valued range.
163.91
P/FCF
Astera Labs Inc. (ALAB) has a current P/FCF of 163.91. The 5-year average P/FCF is 151.39. The thresholds are as follows: Strongly Undervalued below -120.28, Undervalued between -120.28 and 15.56, Fairly Valued between 287.22 and 15.56, Overvalued between 287.22 and 423.05, and Strongly Overvalued above 423.05. The current Forward P/FCF of 163.91 falls within the Historic Trend Line -Fairly Valued range.
Astera Labs Inc (ALAB) has a current Price-to-Book (P/B) ratio of 34.73. Compared to its 3-year average P/B ratio of 14.17 , the current P/B ratio is approximately 145.04% higher. Relative to its 5-year average P/B ratio of 14.17, the current P/B ratio is about 145.04% higher. Astera Labs Inc (ALAB) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 0.55%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 0.55% , the current FCF yield is about -100.00% lower.
34.73
P/B
Median3y
14.17
Median5y
14.17
0.52
FCF Yield
Median3y
0.55
Median5y
0.55
Competitors Valuation Multiple
The average P/S ratio for ALAB's competitors is 0.90, providing a benchmark for relative valuation. Astera Labs Inc Corp (ALAB) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of 149.74%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of ALAB increased by 352.95% over the past 1 year. The primary factor behind the change was an increase in P/E Change from 58.57 to 395.35.
The secondary factor is the Revenue Growth, contributed 149.74%to the performance.
Overall, the performance of ALAB in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch

LDOS
Leidos Holdings Inc
190.115
USD
+1.19%

CFG
Citizens Financial Group Inc
53.440
USD
+1.69%

PUK
Prudential PLC
27.920
USD
+0.32%

TS
Tenaris SA
35.490
USD
+2.07%

BEKE
Ke Holdings Inc
19.000
USD
-1.76%

NTRA
Natera Inc
178.825
USD
-0.20%

STE
STERIS plc
250.810
USD
+0.44%

BCE
BCE Inc
23.140
USD
+0.30%

FTS
Fortis Inc
49.070
USD
-0.14%

ZBRA
Zebra Technologies Corp
321.220
USD
+1.84%
FAQ

Is Astera Labs Inc (ALAB) currently overvalued or undervalued?
Astera Labs Inc (ALAB) is now in the Overvalued zone, suggesting that its current forward PE ratio of 139.22 is considered Overvalued compared with the five-year average of 91.09. The fair price of Astera Labs Inc (ALAB) is between 89.46 to 181.24 according to relative valuation methord. Compared to the current price of 228.00 USD , Astera Labs Inc is Overvalued By 25.80% .

What is Astera Labs Inc (ALAB) fair value?

How does ALAB's valuation metrics compare to the industry average?

What is the current P/B ratio for Astera Labs Inc (ALAB) as of Sep 23 2025?

What is the current FCF Yield for Astera Labs Inc (ALAB) as of Sep 23 2025?

What is the current Forward P/E ratio for Astera Labs Inc (ALAB) as of Sep 23 2025?
